Dr. von Hauner Children's Hospital
Department of Pediatrics
Pediatrician, PhD in Immunology with Sophie Hambleton in Newcastle upon Tyne, Pediatric respiratory fellow at Hauner Children's Hospital in Munich.

Presenter of 1 Presentation

ABERRANT INFLAMMATORY RESPONSES TO TYPE I INTERFERON IN STAT2 OR IRF9 DEFICIENCY

Session Type
Parallel Sessions
Date
Fri, 14.10.2022
Session Time
10:30 - 12:00
Room
Plenary Hall
Lecture Time
11:42 - 11:52

Abstract

Background and Aims

Inflammatory phenomena such as hyperinflammation or hemophagocytic lymphohistiocytosis are a frequent yet paradoxical accompaniment to viral susceptibility in patients with impairment of type I IFN (IFN-I) signalling caused by deficiency of STAT2 or IRF9.

We hypothesized that altered and/or prolonged IFN-I signalling contributes to inflammatory complications in these patients.

Methods

We explored the signalling kinetics and residual transcriptional responses of IFN-stimulated primary cells from individuals with complete loss of either STAT1, STAT2 or IRF9 as well as gene-edited iPSC-derived macrophages.

Results

Deficiency of any ISGF3 component suppressed but did not abrogate IFN-I receptor signalling, which was abnormally prolonged in keeping with insufficient induction of negative regulators such as USP18. In cells lacking either STAT2 or IRF9, this late transcriptional response to IFNα2b mimicked the effect of IFNγ.

Conclusions

Our data suggest a model wherein the failure to limit an ineffective antiviral response leads to immune dysregulation. Aberrant IFNAR signalling in STAT2- and IRF9-deficient cells switches the transcriptional output to a prolonged, IFNγ-like response and likely contributes to clinically overt inflammation in these individuals.

Hide